The controversial vaccine, which Bill Gates has heavily invested in, is being rejected by some countries over widespread concerns about side effects and efficacy

RSS Feed

The controversial vaccine, which Bill Gates has heavily invested in, is being rejected by some countries over widespread concerns about side effects and efficacy

February 19th, 2021

Awake Goy

Countries like the U.S., UK, Israel, Saudi Arabia and others have their own regulatory process for granting emergency use approval for vaccines and other drugs, but those countries that lack the necessary regulatory framework rely on WHO to vet vaccines.

WHO’s approval of the vaccines produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India paves the way for 300 million doses of AstraZeneca to reach 145 countries in the first half of 2021, through Bill Gates’ COVAX program.

But while WHO is moving forward, other countries are hitting pause on AstraZeneca amid ongoing reports of side effects and lack of efficacy.

https://childrenshealthdefense.org/defender/who-approves-astrazeneca-vaccine-emergency-use/?utm_source=salsa&eType=EmailBlastContent&eId=e2a06272-0ce9-47c4-85eb-833884a04510

Photo: pixabay.com

Source